Advertisement

Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients

  • Author Footnotes
    a Tel.: +86 13604181083.
    Wei-li Yuan
    Footnotes
    a Tel.: +86 13604181083.
    Affiliations
    Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, No. 117, Nanjing North Street, Heping District, Shenyang, Liaoning 110002, PR China
    Search for articles by this author
  • Author Footnotes
    a Tel.: +86 13604181083.
    Zhi-lei Jin
    Footnotes
    a Tel.: +86 13604181083.
    Affiliations
    Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, No. 117, Nanjing North Street, Heping District, Shenyang, Liaoning 110002, PR China
    Search for articles by this author
  • Author Footnotes
    a Tel.: +86 13604181083.
    Jing-jian Wei
    Footnotes
    a Tel.: +86 13604181083.
    Affiliations
    Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, No. 117, Nanjing North Street, Heping District, Shenyang, Liaoning 110002, PR China
    Search for articles by this author
  • Author Footnotes
    a Tel.: +86 13604181083.
    Zheng-yu Liu
    Footnotes
    a Tel.: +86 13604181083.
    Affiliations
    Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, No. 117, Nanjing North Street, Heping District, Shenyang, Liaoning 110002, PR China
    Search for articles by this author
  • Author Footnotes
    a Tel.: +86 13604181083.
    Lei Xue
    Footnotes
    a Tel.: +86 13604181083.
    Affiliations
    Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, No. 117, Nanjing North Street, Heping District, Shenyang, Liaoning 110002, PR China
    Search for articles by this author
  • Xu-kai Wang
    Correspondence
    Corresponding author. Tel.: +86 024 22892461.
    Affiliations
    Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, No. 117, Nanjing North Street, Heping District, Shenyang, Liaoning 110002, PR China
    Search for articles by this author
  • Author Footnotes
    a Tel.: +86 13604181083.
Published:January 07, 2013DOI:https://doi.org/10.1016/j.bjoms.2012.12.003

      Abstract

      We investigated the clinical efficacy of propranolol in treating proliferating infantile haemangiomas, and the serological changes in vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) during treatment. Propranolol was given orally to 35 infants with proliferating haemangiomas in a dose of 1.0–1.5 mg/kg/day. Hemisphere measurements, the 4-score method, and feedback from parents were used to evaluate the clinical curative effects. An ELISA was used to measure the serum concentrations of VEGF and eNOS before, and 1 and 2 months after, treatment. The response was excellent in 6 patients, good in 16, moderate in 10, and poor in 3. The peripheral serum concentrations of VEGF and eNOS 2 months after treatment were significantly lower than those before treatment (p < 0.01). We conclude that propranolol can be safely and effectively used to treat proliferating infantile haemangiomas. It can reduce the peripheral serum concentrations of VEGF and eNOS in affected children.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Metry D.
        Update on hemangiomas of infancy.
        Curr Opin Pediatr. 2004; 16: 373-377
        • Bennett M.L.
        • Fleischer Jr., A.B.
        • Chamlin S.L.
        • et al.
        Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation.
        Arch Dermatol. 2001; 137: 1208-1213
        • Bruckner A.L.
        • Frieden I.J.
        Hemangiomas of infancy.
        J Am Acad Dermatol. 2003; 48: 477-493
        • Michaud A.P.
        • Bauman N.M.
        • Burke D.K.
        • et al.
        Spastic diplegia and other motor disturbances in infants receiving interferon-alpha.
        Laryngoscope. 2004; 114: 1231-1236
        • Léauté-Labrèze C.
        • Dumas de la Roque E.
        • Hubiche T.
        • et al.
        Propranolol for severe hemangiomas of infancy.
        N Engl J Med. 2008; 358: 2649-2651
      1. Hemangiomas and vascular malformations of the head and neck. vol. 3. Wiley-Liss Inc., New York1999 (p. 57–8, 93–169)
        • Holmes W.J.
        • Mishra A.
        • Gorst C.
        • et al.
        Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
        J Plast Reconstr Aesthet Surg. 2011; 64: 445-451
        • Haggstrom A.N.
        • Drolet B.A.
        • Baselga E.
        • et al.
        Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment.
        Pediatrics. 2006; 118: 882-887
        • Achauer B.M.
        • Chang C.J.
        • Vander Kam V.M.
        Management of hemangioma of infancy: review of 245 patients.
        Plast Reconstr Surg. 1997; 99: 1301-1308
        • Qin Z.P.
        • Liu X.J.
        • Li K.L.
        • et al.
        Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety.
        Zhonghua Yi Xue Za Zhi. 2009; 89 ([in Chinese]): 3130-3134
        • Naouri M.
        • Schill T.
        • Maruani A.
        • et al.
        Successful treatment of ulcerated haemangioma with propranolol.
        J Eur Acad Dermatol Venereol. 2010; 24: 1109-1112
        • Zvulunov A.
        • McCuaig C.
        • Frieden I.J.
        • et al.
        Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
        Pediatr Dermatol. 2011; 28: 94-98
        • Buckmiller L.M.
        • Munson P.D.
        • Dyamenahalli U.
        • et al.
        Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
        Laryngoscope. 2010; 120: 676-681
        • Artman M.
        • Grayson M.
        • Boerth R.C.
        Propranolol in children: safety-toxicity.
        Pediatrics. 1982; 70: 30-31
        • Li L.
        • Ma L.
        Efficacy and adverse effects of propranolol in the treatment of severe hemangiomas in infancy.
        Int J Dermatol Venereol. 2010; 6: 325-327
        • Storch C.H.
        • Hoeger P.H.
        Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.
        Br J Dermatol. 2010; 163: 269-274
        • Ribatti D.
        The crucial role of vascular permeability factor/vascular endothelial factor in angiogenesis: a historical review.
        Br J Haematol. 2005; 128: 303-309
        • Frischer J.S.
        • Huang J.
        • Serur A.
        • et al.
        Biomolecular markers and involution of hemangiomas.
        J Pediatr Surg. 2004; 39: 400-404
        • Zhang L.
        • Lin X.
        • Wang W.
        • et al.
        Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients.
        Plast Reconstr Surg. 2005; 116: 200-204
        • Yang E.V.
        • Sood A.K.
        • Chen M.
        • et al.
        Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.
        Cancer Res. 2006; 66: 10357-10364
        • Al-Wadei H.A.
        • Al-Wadei M.H.
        • Schuller H.M.
        Prevention of pancreatic cancer by the beta-blocker propranolol.
        Anticancer Drugs. 2009; 20: 477-482
        • Ziche M.
        • Morbidelli L.
        • Masini E.
        • et al.
        Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.
        J Clin Invest. 1994; 94: 2036-2044
        • Lei S.S.
        • Tu Y.T.
        • Zhu X.Q.
        • et al.
        Expression of nitric oxide synthase and vascular endothelial growth factor in hemangioma and its relation to angiogenesis.
        Zhong Guo PiFu Xing Bing Xue Za Zhi. 2007; 10 ([in Chinese]): 580-582
        • Westfall T.C.
        • Westfall D.P.
        Neurotransmission: the autonomic and somatic motor nervous systems.
        in: Brunton L.L. Lazo J.S. Parker K.L. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. McGraw-Hill, New York2006: 167
        • Westfall T.C.
        • Westfall D.P.
        Adrenergic agonists and antagonists.
        in: Brunton L.L. Lazo J.S. Parker K.L. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. McGraw-Hill, New York2006: 271-295